Shangge Xu
Datos Biográficos
| ID | 7293546 |
|---|---|
| NOMBRE | Shangge Xu |
| NOMBRES | Shangge |
| APELLIDO | Xu |
| FIRMA | XU S |
| AFILIACIONES | Guangzhou University of Chinese Medicine |
| VERIFICADO | No |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAS | 0 |
| OBRAS COMO AUTOR | 1 |
| OBRAS COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2026 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 0 |
Zhichuanling oral liquid attenuates airway inflammation in asthma by targeting the STIM1/CHOP/JNK axis
ZCLOL alleviates airway inflammation and hyperresponsiveness in asthma by restoring Ca 2+ homeostasis and suppressing ERS through inhibition of the STIM1/CHOP/JNK axis. These findings provide mechanistic evidence supporting ZCLOL as a potential multi-target therapeutic strategy for asthma
Sin obras prominentes en esta página.
Zhichuanling oral liquid attenuates airway inflammation in asthma by targeting the STIM1/CHOP/JNK axis
ZCLOL alleviates airway inflammation and hyperresponsiveness in asthma by restoring Ca 2+ homeostasis and suppressing ERS through inhibition of the STIM1/CHOP/JNK axis. These findings provide mechanistic evidence supporting ZCLOL as a potential multi-target therapeutic strategy for asthma
Airway (1 obra) · Airway hyperresponsiveness (1 obra) · Asthma (1 obra) · Bronchial hyperresponsiveness (1 obra) · Homeostasis (1 obra) · Inflammasome and immune disorders (1 obra) · Inflammation (1 obra) · Inhalation and Respiratory Drug Delivery (1 obra) · Ion Channels and Receptors (1 obra)